Conditions

Autism

Autism spectrum disorder (ASD) is a group of a neurodevelopmental disorders associated with significant social, communication and behavioral challenges. The spectrum refers to the wide range of symptoms and levels of disability among those affected. The rate of Autism has steadily increased over the past few decades and now affects 1 in 59 children with over half classified as having an intellectual or borderline intellectual disability. ASD occurs in all racial, ethnic and socioeconomic groups and is 4 times more common in boys.

Although there is no cure for autism early intervention and treatment can improve a child’s development and quality of life. Individuals with autism often have other medical conditions such as allergies, asthma, epilepsy, digestive disorders, ADHD, OCD, persistent viral infections, sleep disorders and more. ASD has also been shown to be associated with immune dysregulation and neuro-inflammation.

Current conventional management of ASD includes interventions such as psychological, behavior, cognitive and speech therapies and symptom management using medications such as anti-depressants, anti-psychotics, etc., which often have significant side effects. Considering the current approach is rather limited and does not always confer with significant benefits, patients, care givers, clinicians and researchers alike continue to search for more effective therapies.

Numerous research studies have demonstrated that stem cell therapy is safe, well tolerated and feasible in children with ASD. Stem cell therapy has been shown to not only reduce inflammatory markers and influence changes to the central nervous system but also improve behavior, socializing, nonverbal communication, and lethargy in children with ASD. These benefits and other therapeutic properties make stem cell therapy a promising option in the treatment of ASD.

Based on early human clinical trials there appears to be a strong argument for the safe and effective use of stem cell therapy in the treatment of ASD. While we wait for phase II/III trials the current data is encouraging and supports use of stem cell therapy in the clinical setting.

Proven Benefits of Stem Cell Therapy in ASD

• Reduction of inflammatory markers in blood (Riordan et al)
• Significant improvements in behavior, socialization and communication (Dawson et al)
• Trends toward improved socialization (Chez et al)
• Improvement in visual, emotional and intellectual responses (Lv et al)
• Improvement in lethargy/social withdrawal, hyperactivity and inappropriate speech (Lv et al)
• Improvement in ASD symptom score with patients achieving less severe symptom category (Riordan et al)

Specific Conclusions from Selected Studies

“The administration of repeated-dose UC-MSC infusions is safe and tolerable for patients with ASD. Although this phase I study included a small number of subjects without a placebo arm, the trends observed in this study are indicative of potential therapeutic benefits reflected in lower CARS and ATEC scores that may be associated with decreases in TARC and MDC levels.”

• Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels (Riordan et al 2019)

“This research suggests that stem cells from autologous cord blood are safe and potentially have an impact on socialization for children with autism.”

• Safety and Observations from a Placebo-Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism (Chez et al 2018)

“We demonstrated in an open label, phase I trial that intravenous infusion of autologous umbilical cord blood in young children with ASD is safe and feasible. We describe significant improvements in behavior observed in the first 6 months post-infusion and sustained at 12 months.”

• Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial (Dawson et al)

“In summary, CBMNC and UCMSC transplantation may improve some behavioral symptoms and function observed in children with autism. This study presents for the first time a safety and efficacy analysis of using allogeneic CBMNCs and UCMSCs to treat behaviors in addition to conventional behavioral therapy in autism.”

• Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism (Lv et al)

For additional information on stem cell therapy in ASD and more details regarding these studies please visit our Research Archive

.

SOURCES

• https://nationalautismassociation.org/resources/autism-fact-sheet/
• https://www.cdc.gov/ncbddd/autism/facts.html
• https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Autism-Spectrum-Disorder-Fact-Sheet
• Riordan, N. H., Hincapié, M. L., Morales, I., Fernández, G., Allen, N., Leu, C., … Novarro, N. (2019). Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels. Stem Cells Translational Medicine. https://doi.org/10.1002/sctm.19-0010

Stem Cell Therapy Survey

Take our stem cell therapy survey to see how stem cell therapy will best work for you, get you the information you are looking for, and help you on your journey to good health and wellness.

Take Survey Now